...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma
【24h】

Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma

机译:Epstein-Barr病毒编码的miR-BART3 * microRNA在鼻咽癌中靶向DICE1肿瘤抑制物

获取原文
获取原文并翻译 | 示例

摘要

Latent infection with Epstein-Barr virus (EBV) is associated with several types of malignancies including nasopharyngeal carcinoma (NPC), which is particularly more prevalent in Southern China. EBV expresses at least 44 mature microRNAs (miRNAs) to modulate the activity of viral and cellular RNAs, but the targets of these EBV-encoded miRNAs in NPC are not well understood. In this report, we characterized DICE1 tumor suppressor to be a cellular target of EBV miR-BART3* miRNA. miR-BART3* was abundantly expressed in NPC cells. The target site of miR-BART3* located in the 3′-untranslated region of DICE1 transcript was identified and characterized. Enforced expression of miR-BART3* or its precursor pre-miR-BART3 led to down-regulation of endogenous DICE1 expression. Inhibition of endogenous miR-BART3* in NPC cells with anti-miR-BART3* oligonucleotide inhibitor resulted in increased expression of DICE1 protein. On the contrary, expression of miR-BART3* overcame the growth suppressive activity of DICE1 and stimulated cell proliferation. Consistent with its tumor suppressive function, DICE1 was underexpressed in EBV-expressing NPC tumor tissues. Taken together, our findings suggest that EBV encoded miR-BART3* miRNA targets DICE1 tumor suppressor to promote cellular growth and transformation in NPC. What's new? While there is a known link between Epstein-Barr virus (EBV) and nasopharyngeal carcinoma (NPC), the roles of EBV and its oncoproteins in NPC tumorigenesis remain poorly understood. Here the authors looked at EBV-encoded microRNAs and their potential targets in NPC. They found that DICE1 tumor suppressor was a cellular target of an EBV miRNA abundantly expressed in transfected and infected cells as well as in NPC tumor samples. This is the first report of an EBV microRNA targeting a tumor suppressor in NPC. The findings provide a new mechanism in NPC tumorigenesis and reveal potential new targets for therapy.
机译:EB病毒(EBV)的潜伏感染与多种类型的恶性肿瘤有关,包括鼻咽癌(NPC),在中国南方尤为普遍。 EBV至少表达44种成熟的microRNA(miRNA)来调节病毒和细胞RNA的活性,但这些EBV编码的miRNA在NPC中的靶标尚不清楚。在本报告中,我们将DICE1肿瘤抑制因子定性为EBV miR-BART3 * miRNA的细胞靶标。 miR-BART3 *在NPC细胞中大量表达。鉴定并鉴定了位于DICE1转录本3'非翻译区的miR-BART3 *的靶位点。 miR-BART3 *或其前体miR-BART3的表达增强导致内源性DICE1表达下调。用抗miR-BART3 *寡核苷酸抑制剂抑制NPC细胞中的内源性miR-BART3 *导致DICE1蛋白表达增加。相反,miR-BART3 *的表达克服了DICE1的生长抑制活性并刺激了细胞增殖。与其肿瘤抑制功能一致,DICE1在表达EBV的NPC肿瘤组织中表达不足。两者合计,我们的发现表明,EBV编码的miR-BART3 * miRNA靶向DICE1肿瘤抑制因子,以促进NPC中的细胞生长和转化。什么是新的?虽然爱泼斯坦-巴尔病毒(EBV)和鼻咽癌(NPC)之间存在已知的联系,但对EBV及其癌蛋白在NPC肿瘤发生中的作用仍知之甚少。在这里,作者研究了EBV编码的microRNA及其在NPC中的潜在靶标。他们发现DICE1抑癌剂是EBV miRNA的细胞靶标,该EBV miRNA在转染和感染的细胞以及NPC肿瘤样品中大量表达。这是针对NPC中肿瘤抑制物的EBV微小RNA的首次报道。这些发现为鼻咽癌的发生提供了新的机制,并揭示了潜在的治疗新靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号